Should Gleason score 7 prostate cancer be considered a unique grade category? - the John Hopkins experience after 10 years

By Tefilli M.V.   Gheiler E.L.   Tiguert R.   Sakr W.   Grignon D.J.   Banerjee M.   Pontes J.E.   Wood D.P.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 372-377

Elsevier

Access to resources Recommend Favorite

Probability of biochemical recurrence by analysis of pathologic stage, gleason score, and margin status for localized prostate cancer

By Khan M.A.   Partin A.W.   Mangold L.A.   Epstein J.I.   Walsh P.C.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 866-871

Elsevier

Access to resources Recommend Favorite

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy

By Merrick G.S.   Butler W.M.   Galbreath R.W.   Lief J.H.   Adamovich E.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 98-103

Elsevier

Access to resources Recommend Favorite

Gleason Score Predicts Androgen Independent Progression after Androgen Deprivation Therapy

By Benaim E.A.   Pace C.M.   Roehrborn C.G.  

European Urology, Vol. 42, Iss. 1, 2002-07 ,pp. : 12-17

Elsevier

Access to resources Recommend Favorite

DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality

By Baak J.P.A.   Bol M.G.W.   van Diermen B.   Janssen E.A.M.   Buhr-Wildhagen S.B.K.   Mestad O.   OGreid P.   Kjellevold K.-H.  

Urology, Vol. 61, Iss. 6, 2003-06 ,pp. : 1266-1272

Elsevier

Access to resources Recommend Favorite